|
HS Code |
800263 |
| Generic Name | Otilonium Bromide |
| Chemical Formula | C28H41BrN2O4 |
| Molecular Weight | 549.54 g/mol |
| Therapeutic Class | Antispasmodic agent |
| Indications | Irritable bowel syndrome (IBS) |
| Route Of Administration | Oral |
| Mechanism Of Action | Calcium channel blocker in smooth muscle |
| Appearance | White or almost white powder |
| Solubility | Slightly soluble in water |
| Atc Code | A03AB03 |
| Cas Number | 26095-59-0 |
| Brand Names | Spasmomen, Otilon, Dicetel |
| Bioavailability | Low systemic absorption |
| Side Effects | Dry mouth, nausea, abdominal pain |
| Contraindications | Hypersensitivity to otilonium bromide |
As an accredited Otilonium Bromide factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Otilonium Bromide, 25g, is supplied in a sealed, amber glass bottle with a tamper-evident cap, labeled for laboratory use. |
| Shipping | Otilonium Bromide should be shipped in tightly sealed containers, protected from light and moisture. Store at room temperature and handle with appropriate safety measures. Transport according to relevant regulations for chemicals, ensuring proper labeling and documentation. Avoid contact with incompatible substances and prevent release into the environment during transit. |
| Storage | Otilonium Bromide should be stored in a tightly sealed container, protected from light and moisture. Keep it at room temperature, ideally between 15–30°C (59–86°F), away from incompatible materials, acids, and oxidizing agents. Ensure the storage area is well-ventilated, cool, and dry. Access should be limited to authorized personnel trained in chemical handling and safety protocols. |
|
Purity 99%: Otilonium Bromide with purity 99% is used in gastrointestinal spasm treatment, where rapid symptom reduction is achieved. Molecular Weight 424.3 g/mol: Otilonium Bromide of molecular weight 424.3 g/mol is used in irritable bowel syndrome formulations, where targeted antispasmodic activity is provided. Melting Point 198°C: Otilonium Bromide with a melting point of 198°C is used in solid oral dosage manufacturing, where thermal stability ensures consistent product quality. Particle Size <50 μm: Otilonium Bromide with particle size less than 50 μm is used in tablet production, where enhanced dissolution rates improve bioavailability. Stability Temperature 25°C: Otilonium Bromide with stability at 25°C is used in long-term storage applications, where extended shelf life is secured. Hydrate Form: Otilonium Bromide in hydrate form is used in pediatric pharmaceutical preparations, where improved solubility optimizes dosing precision. Residue on Ignition <0.1%: Otilonium Bromide with residue on ignition less than 0.1% is used in parenteral formulations, where minimized impurities enhance safety profiles. Moisture Content <0.5%: Otilonium Bromide with moisture content below 0.5% is used in high-speed manufacturing, where reduced hygroscopicity prevents caking and ensures process efficiency. |
Competitive Otilonium Bromide prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Digestive problems have always found a way to interfere with daily life. Even a garden-variety case of abdominal cramps or excessive bloating can turn a routine meeting into a struggle for composure. There’s no shortage of over-the-counter remedies in the pharmacy aisle, but few have gained the trust of physicians in the same way as Otilonium Bromide. As someone with family members who have occasionally wrestled with irritable bowel issues, seeing their frustration and fatigue made the quest for a reliable treatment feel personal. Otilonium Bromide offers a different approach from antispasmodics of the past, and anyone who’s experienced that internal tug-of-war will understand why these differences matter.
Under the hood, Otilonium Bromide is a quaternary ammonium compound, developed specifically to help control intestinal motility. Its model of action feels less like a blunt instrument and more like a carefully tuned tool. Unlike the more common hyoscine derivatives or anticholinergics that leave patients drowsy or dry-mouthed, this product was designed to focus solely on the gut. It blocks calcium channels within the gastrointestinal tract, which means it moderates spasms directly at their source. That narrower focus helps many users avoid the scattershot side effects so typical of older muscle relaxants.
The most widely used format is the 40 mg tablet, given in cycles as directed by a healthcare provider. This isn’t a product for daily, indefinite use; it’s better suited for managing flare-ups or periods of particular discomfort. Extensive clinical data reflect its consistent safety record when patients follow basic dosing advice. Those living with a sensitive gut often describe a subtle but important difference after a typical course: symptoms like abdominal pain, bloating, and those all-too-common erratic bowel habits recede into the background.
Many people have grown skeptical of “gut health” products—often for good reason. The supplement market is crowded with solutions that either mask symptoms or try to treat the mind and body together, sometimes with little regard for what’s proven. Otilonium Bromide doesn’t promise to be a cure-all. Its mission is narrower, focusing on symptom relief for chronic irritable bowel syndromes and related complaints.
That focus shows up most in real-world stories. Users who report little success with peppermint oil, probiotics, or bulk-forming agents find something refreshingly direct here. Relief comes not by sedating the entire body, but by easing the contractions that create pain and urgency. For many gastroenterologists, Otilonium Bromide represents an advance not only in symptom control, but in predictability—an important detail if you’ve ever needed to manage a busy day while worrying about when your next bathroom dash might happen.
Modern medicine demands a high bar for proof, especially in the world of functional digestive disorders. Reliable evidence comes not only from what is seen in the clinic, but from a range of peer-reviewed trials. Several large-scale studies have tested Otilonium Bromide among patients with moderate to severe irritable bowel symptoms, and the majority have reported statistically significant improvements in abdominal pain, cramping, and overall comfort. European guidelines recognize the product as one of the best-studied options for irritable bowel syndrome, placing it at the top tier alongside a select group of trusted antispasmodics.
Safety matters as much as effectiveness. Otilonium Bromide is notable for staying mostly within the gut. After ingestion, only a small fraction crosses into the bloodstream, which helps keep systemic side effects to a minimum. Compared to alternatives that trigger drowsiness, dry mouth, or blurred vision, patients have found this product allows for a more normal daily routine. This advantage carries extra weight for older adults or anyone sensitive to the “anticholinergic burden” that comes with less targeted drugs.
Life can feel unpredictable enough—the last thing anyone needs is gastrointestinal trouble adding an extra layer of uncertainty. Otilonium Bromide doesn't claim to fix the root complications of chronic digestive disorders, but in most cases, it acts as a bridge to a more manageable day. With a dosing schedule set by a physician, the patient has a concrete plan: take the prescribed amount, usually before meals, and stand a much better chance of smooth sailing through meetings or social events. The regular tablet formula reduces the temptation to self-medicate or overuse, another pitfall with many short-acting remedies.
Unlike drugs that come with a long list of food or drug interactions, Otilonium Bromide keeps things relatively simple. Most clinical experiences suggest it does not interfere with cardiovascular medications, antibiotics, or the common arsenal of over-the-counter pain relievers. This trait lets users stay focused on managing their core symptoms without worrying about ripple effects across other chronic conditions.
The world of antispasmodic therapy is crowded, but not all options stack up equally. For years, compounds like dicyclomine or mebeverine served as front-line solutions for irritable bowel complaints. They work for some, but their effects spread throughout the body, often with limitations that steer both patients and prescribers toward alternatives. Otilonium Bromide stands out because its absorption stays mainly in the digestive tract, acting right where it’s needed and sparing other body systems.
This difference holds real-world importance. Imagine a teacher, a long-haul driver, or anyone whose job punishes a foggy head or slowed response. Drugs that cross into the brain or act all over the nervous system can get in the way of work and family life. Otilonium Bromide’s focused profile often helps users sidestep the trade-off between symptom relief and mental alertness. There’s nothing miraculous, just fewer unwanted surprises.
Stories from users across several countries repeat similar themes. Patients describe a quieter digestive system—less gas, fewer urgent trips to the bathroom, a feeling that routine meals aren’t followed by unpredictable pain or cramping. Young adults preparing for exams or athletes who need to stay focused during competition value these benefits, but so do retirees who have simply grown tired of planning life around flare-ups.
Not every story is the same. Otilonium Bromide is not for everybody. Sometimes, those with severe constipation or certain rare medical conditions need to look elsewhere for help. And for those seeking a magic bullet divorced from healthy lifestyle changes, disappointment may follow. Still, for those whose symptoms resist dietary tweaks and run-of-the-mill fiber supplements, Otilonium Bromide provides a next step that feels grounded in both science and lived experience.
For years, Otilonium Bromide has enjoyed a well-established regulatory presence in European markets, and its reputation for solid quality and traceable sourcing stands out. Its manufacturing involves pharmaceutical-grade standards, and regulatory agencies regularly review batches for content and purity. The product does not claim to resolve every digestive issue, but its place in medical guidelines reflects a track record that matters to both doctors and patients. While not universally available in every country, regions with access have seen health services include it among core recommendations for irritable bowel-related pain.
The story of Otilonium Bromide highlights larger gaps in the approach to chronic digestive conditions. Too many people resort to multiple products, chasing the shifting frontiers of gut health. The rise of unsupported supplements, digital detoxes, cleansing kits, and other fads shows the demand for legitimate answers. A more robust combination of physician education, patient advocacy, and access to targeted therapies could make a difference. Otilonium Bromide offers an example of where science and practical medicine can meet: a treatment with clear boundaries that neither overpromises nor underdelivers.
Improved communication between patients and healthcare providers remains a missing ingredient in many cases. Patients often underreport their symptoms out of embarrassment or frustration; doctors sometimes dismiss abdominal pain as a phase or attribute it to stress. Encouraging more open, detailed dialogue about symptom patterns, trigger foods, and treatment responses allows for better use of precision therapies like Otilonium Bromide, as well as earlier identification of those who need a different path altogether.
The surge of interest in microbiome science, dietary triggers, and personalized care has changed expectations about how gut health should be managed. Medications like Otilonium Bromide that feature specific mechanisms and clean side effect profiles point to the direction future therapy should take. Combining well-studied drugs with consistent lifestyle coaching and psychological support could improve the lives of millions dealing with chronic discomfort.
This remains a wider project, and more work is needed on both education and access. Many patients in resource-limited areas still rely on outdated or poorly regulated products, while others try online “miracle solutions” rather than approaching a doctor. Efforts to expand availability of targeted treatments like Otilonium Bromide, alongside better training in primary care, could help correct this imbalance. Health authorities and advocacy groups can also play a role, by highlighting what real clinical evidence supports and what simply doesn’t measure up.
Nobody should have to feel out of options when dealing with the pain and uncertainty that can come with digestive dysfunction. Not every stomach cramp calls for a prescription, but for those whose symptoms disrupt sleep, relationships, or work, quality of life takes a hit. Otilonium Bromide isn’t a silver bullet; it represents honest progress—a treatment with a clarified role in a wider, evidence-based approach to gut health.
In the ever-growing field of digestive care, clarity carries as much weight as innovation. Otilonium Bromide shows how the right treatment can bring meaningful relief to those who need it, without expecting patients to trade comfort for alertness or hope for blind faith. Its focused action and strong safety record stand as a reminder: the best solutions come from the space where science, experience, and practicality cross. That’s worth remembering and worth building on, for patients and practitioners alike.